One of your friends has shared a page with you.You can click the link above to view this page.

NIH Supports Research on Neuromodulation

BioPhotonicsMar 2018
ROCKVILLE, Md. — Researchers from Case Western Reserve University’s School of Medicine, Vanderbilt University and the University of Pittsburgh have received a four-year, $9 million grant from the National Institutes of Health to develop enhanced IR neuromodulation for potentially treating a variety of diseases including cardiac arrhythmias, high and low blood pressure, asthma, sleep apnea and diarrhea.

Depending on the need, IR neuromodulation can stimulate or inhibit electrical signals that alter important bodily functions by targeting specific areas of the nervous system or even single nerve cells with laser precision. The multidisciplinary team of researchers led by Michael W. Jenkins, assistant professor of pediatrics and biomedical engineering at Case Western Reserve University’s School of Medicine, will examine the effects of neuromodulation on various nerve structures including the nodose ganglion, a cluster of cells that sends and receives control signals for several organs. Many of the cells in the nodose ganglion connect to these organs through the vagus nerve to manage such vital actions as heart rate, respiration and digestion. As part of the autonomic nervous system, these physiological processes are not under direct conscious control.

"We have recently shown that IR neuromodulation can alter blood pressure and respiration, often generating results not currently possible with electrical current or drugs," Jenkins said. "Our aim is to create a better understanding of how this process can be used for treating human diseases."

Under the grant, the researchers will develop new technologies to precisely send IR light to nerves and ganglia in animals, watch the ensuing activity, and map the molecular components in 3D with high resolution. By delivering light to various locations, some never before assessed with this level of precision, and following resultant activity and molecular constituents of the cells, Jenkins and his colleagues expect to gain a better understanding of how IR light blocks or induces electrical signals at the cellular level, knowledge which is crucial for treating patients in the future.

"Different parts of the nodose ganglion affect different parts of the body," said Stephen J. Lewis, professor of pediatrics at Case Western Reserve University’s School of Medicine and a member of the research team. "If we want to lower blood pressure, we can target one part of the ganglion with IR light. If we want to stop diarrhea, we target the part that controls peristalsis, which pushes ingested food through the digestive tract toward its release at the anus. By slowing peristalsis down, we can stop diarrhea from taking a fatal toll on people, especially young children in less developed countries, who are particularly susceptible to death from dehydration."

In addition, as part of their efforts at better understanding how IR neuromodulation works, the researchers will develop computational models to simulate mechanisms by which the light interacts with tissue and affects neural signaling.